Delivery Order SPE2DR25D3011-SPE2DR26FW45D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,928.15 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count) valued at $6,118.16 with a firm fixed price structure. This competitively awarded, non-set-aside contract was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.35 to AmerisourceBergen Drug Corp for 60 capsules of Rifampin 300 mg, with a completion date of September 2, 2025. The contract employs firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $31,201.41. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for the supply of Rifampin 300 mg capsules (60-count units) at a ceiling value of $1,720.96. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by July 29, 2025. The award falls under AmerisourceBergen's larger Indefinite...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,956,698 units of Rifampin 300 mg capsules. The contract, valued at $1,203.66, has an ultimate completion date of March 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules. The order is valued at $6,351.40 and has a period of performance through August 30, 2024. This delivery order is placed against an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which has a potential value of up to $999,999,999 and provides a broad range of pharmaceutical and medical supplies to military...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 60 count bottles of 300mg Rifampin capsules. The $5,089.84 contract has a performance period through February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under a larger indefinite delivery contract (IDC) with a potential value of...
- The Defense Logistics Agency awarded a $9,629.19 delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a task order under AmerisourceBergen's parent company Cencora,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,953.93 by the Defense Logistics Agency (DLA) for the supply of Rifampin 150 mg capsules in quantities of 30, with an ultimate completion date of September 3, 2025. The contract employs firm fixed-price pricing and was competitively awarded without any set-aside designation. Performance will be executed from the company's Conshohocken, Pennsylvania location, which serves as its corporate headquarters. This delivery order...
- SPE2DR25D3011Indefinite Delivery Contract
- SPE2DR25D3011-SPE2DR26FW45DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $52,050.92 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with a completion date of January 29, 2026. This non-set-aside, firm fixed-price contract was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly known as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement needs serving military and veteran healthcare systems. The company's extensive contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. Through its DLA relationship and other federal partnerships, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning itself as a key strategic partner in the military's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.1k | 1/27/26 |